Isolated Intermetatarsal Ligament Release as Primary Operative Management for Morton's Neuroma: Short-term Results

Foot Ankle Spec. 2022 Aug;15(4):338-345. doi: 10.1177/1938640020957851. Epub 2020 Sep 19.

Abstract

Background: Although the precise pathoetiology of Morton's neuroma remains unclear, chronic nerve entrapment from the overlying intermetatarsal ligament (IML) may play a role. Traditional operative management entails neuroma excision but risks unpredictable formation of stump neuroma.

Materials and methods: Medical records were examined for adult patients who failed at least 3 months of conservative treatment for symptomatic and recalcitrant Morton's neuroma and who then underwent isolated IML decompression without neuroma resection.

Results: A total of 12 patients underwent isolated IML decompression for Morton's neuroma with an average follow-up of 13.5 months. Visual Analog Pain Scale averaged 6.4 ± 1.8 (4-9) preoperatively and decreased to an average of 2 ± 2.1 (0-7) at final follow-up (P = .002). All patients reported significant improvement.

Conclusion: Isolated IML release of chronically symptomatic Morton's neuroma shows promising short-term results regarding pain relief, with no demonstrated risk of recurrent neuroma formation, permanent numbness, or postoperative symptom exacerbation.

Level of evidence: Level IV: Case series.

Keywords: Morton’s neuroma; intermetatarsal ligament decompression.

MeSH terms

  • Adult
  • Foot
  • Humans
  • Ligaments, Articular / surgery
  • Morton Neuroma* / surgery
  • Neuroma* / surgery
  • Retrospective Studies